SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer

SET and MYND domain-containing protein 3 (SMYD3) is a lysine methyltransferase, and its aberrant expression has been implicated in several malignancies. However, its clinical and biological roles in non-small cell lung cancer (NSCLC) remain unclear. In the present study, it was revealed that SMYD3 w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Oncol
Autors principals: Li, Jing, Zhao, Lifang, Pan, Yunjian, Ma, Xiao, Liu, Li, Wang, Wuzhang, You, Wenjie
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2020
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7384847/
https://ncbi.nlm.nih.gov/pubmed/32705243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2020.5095
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars